ESCO1 Inhibitors
Chemical inhibitors of ESCO1 can impinge upon its enzymatic activity through various molecular mechanisms. Trichostatin A, a potent histone deacetylase inhibitor, can increase the levels of acetylation within the cell. This upsurge in acetylated substrates can lead to a competitive environment for ESCO1, as it may struggle to access the necessary acetyl groups for its action or face altered protein interactions that hinder its function. Similarly, C646 targets p300/CBP histone acetyltransferase and, although not directly inhibiting ESCO1, can disrupt the acetylation balance within the cell, which may inadvertently affect the activity of ESCO1 by changing the acetylation status of proteins that interact with or regulate ESCO1. Anacardic Acid, another histone acetyltransferase inhibitor, may create a less conducive environment for the acetyltransferase family, thereby reducing ESCO1's acetyltransferase activity. Garcinol and Curcumin, both known to inhibit histone acetyltransferases, can block the functional activity of ESCO1 by either directly inhibiting its acetyltransferase activity or by affecting the cellular acetyl-CoA pool, which is vital for ESCO1's action.
Moreover, MB-3, through its histone acetyltransferase inhibitory action, can alter the cellular acetylation landscape, which may modify the pool of acetyl-CoA or change the acetylation patterns that are essential for ESCO1's proper functioning. Sirtinol, primarily a sirtuin deacetylase inhibitor, can still indirectly influence ESCO1 by shifting the regulatory acetylation dynamics that ESCO1 depends on for its activity. BIX-01294 and EPZ004777, which are inhibitors of histone methyltransferases, can alter chromatin structure and methylation status, respectively, potentially affecting the activity of ESCO1 by changing the accessibility or the modification state of its substrates. RG108, by inhibiting DNA methyltransferase, may impact the binding and activity of chromatin-associated proteins like ESCO1, thereby indirectly affecting its enzymatic role. Lastly, Mocetinostat and SAHA, both histone deacetylase inhibitors, can increase the competition for acetyl groups, which may indirectly disrupt the normal functioning of ESCO1 due to altered acetyl-CoA dynamics or acetylation patterns within the cell. Each of these inhibitors, by altering the acetylation equilibrium or the chromatin landscape, can modulate the activity of ESCO1 without directly targeting the protein itself.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. ESCO1 functions in cohesion establishment during the S phase of the cell cycle by modifying the cohesin complex, which requires acetylation. By inhibiting histone deacetylase, Trichostatin A can increase the acetylation levels in cells, leading to a possible competition for acetyl groups or altered protein interactions, thereby inhibiting the activity of acetyltransferases like ESCO1. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a p300/CBP histone acetyltransferase inhibitor. Although p300 and CBP are not ESCO1, they are related to acetyltransferase activity. C646 could potentially lead to changes in global acetylation patterns, which may indirectly inhibit ESCO1 by disrupting its substrate recognition or by altering the acetylation status of proteins that interact with or regulate ESCO1. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Anacardic Acid is an inhibitor of histone acetyltransferase activity. As ESCO1 is a member of the acetyltransferase family, the chemical environment influenced by Anacardic Acid may become less favorable for acetyltransferases, potentially leading to a reduction in ESCO1's activity. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $124.00 $502.00 | 13 | |
Garcinol is known to inhibit histone acetyltransferases. Given that ESCO1 has acetyltransferase activity, the presence of Garcinol could inhibit the function of ESCO1 by directly blocking its acetyltransferase activity or by altering the cellular acetyl-CoA levels or equilibrium. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is a compound that has been found to inhibit histone acetyltransferase. By inhibiting this activity, it could create a cellular state where the acetyl-CoA pool is affected, potentially inhibiting ESCO1 by limiting its substrate availability or by indirectly altering its activity through changes in the acetylation state of the cell. | ||||||
Sirtinol | 410536-97-9 | sc-205976 sc-205976A | 1 mg 5 mg | $38.00 $113.00 | 14 | |
Sirtinol is an inhibitor of the sirtuin family of deacetylases. While it primarily inhibits deacetylases, its impact on the balance of acetylation within the cell could indirectly inhibit ESCO1 by altering the regulatory acetylation landscape that ESCO1 interacts with. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
BIX-01294 is a histone methyltransferase inhibitor. Though its primary target is not acetylation, by changing histone methylation status, it could indirectly affect the functions of acetyltransferases such as ESCO1 by altering chromatin structure and accessibility. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
EPZ004777 is a selective inhibitor of the histone methyltransferase DOT1L. While this does not directly affect acetyltransferase activity, the resulting changes in chromatin structure could indirectly impact ESCO1's ability to access or modify its substrates. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor. The inhibition of DNA methylation could lead to a more open chromatin state, which may affect the binding and activity of chromatin-associated proteins like ESCO1, hence indirectly inhibiting its function. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat is a histone deacetylase inhibitor that could potentially increase the competition for acetyl groups within the cell, indirectly inhibiting ESCO1 by disrupting its normal acetylation function due to altered acetyl-CoA dynamics or acetylation patterns. | ||||||